Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-asparaginase, Methotrexate, and Dexamethasone for Nasal NK/T-cell Lymphoma
NCT00283985Phase 2Completed
- Sponsor
- CHU de Limoges
- Start
- Feb 2006
- Primary completion
- Jun 2012
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Asparaginase in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by CHU de Limoges. Started Feb 2006; status: completed.
02
Drugs
Asparaginase
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT00283985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283985.